Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Avian Influenza
Contract awarded to develop vaccine against H9N2 avian influenza
September 8th, 2004
The National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH), has awarded a contract to Chiron Corp. of Emeryville, California, for the production of an investigational vaccine based on an H9N2 strain of avian influenza virus that has infected humans and has the potential to trigger a modern-day pandemic. This project, which is part of the NIAID Pandemic Influenza Preparedness Program, is the second recently announced by NIAID that supports the development and production of a candidate vaccine against a pandemic strain of avian influenza. The other NIAID project targets the H5N1 strain that has resurfaced in...
Source: Vaccine Weekly (2004-09-08)
|
